| Inventis Limited (IVT) ORDINARY FULLY PAID |
Industrials |
- |
Announcement Update regarding IVT group structure
|
5 Aug 2025 9:38AM |
$0.010 |
$0.010 |
fallen by
0%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$41 |
Notice under Section 708A(5)(e) of the Corporations Act 2001
|
5 Aug 2025 9:34AM |
$0.035 |
$0.195 |
risen by
457.14%
|
|
| Prescient Therapeutics Limited (PTX) ORDINARY FULLY PAID |
Health Care |
$56 |
Application for quotation of securities - PTX
|
5 Aug 2025 9:33AM |
$0.043 |
$0.053 |
risen by
23.26%
|
|
| D3 Energy Limited (D3E) ORDINARY FULLY PAID |
Energy |
$37 |
RBD10 re-test confirms unique reservoir characteristics
|
5 Aug 2025 9:33AM |
$0.335 |
$0.420 |
risen by
25.37%
|
|
D3E - Price-sensitive ASX Announcement
Full Release
Key Points
- RBD10 well re-test confirms unique reservoir characteristics.
- Test results provide improved data quality compared to prior assessments.
- High reservoir pressure support and a productive fracture system were observed.
- Findings align with previous technical interpretations and expectations.
- Results support the future development and planning for the D3E field.
- The re-test is strategically important for further appraisal and production planning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$86 |
LRT NAV Estimate - 1 August 2025
|
5 Aug 2025 9:32AM |
$1.430 |
$2.080 |
risen by
45.45%
|
|
| Brickworks Limited (BKW) ORDINARY FULLY PAID |
Materials |
- |
BKW Notice of Meeting - Approval of Topco MD & CEO FY26 LTI
|
5 Aug 2025 9:31AM |
$32.810 |
$33.020 |
risen by
0.64%
|
|
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$195 |
Dividend/Distribution - WMA
|
5 Aug 2025 9:31AM |
$1.000 |
$0.990 |
fallen by
1%
|
|
WMA - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Alternative Assets Limited (WMA) declared a fully franked final dividend of 2.25 cents per share.
- The dividend relates to the financial year ending 30 June 2023.
- The payment date is set for 18 August 2023.
- The record date for the dividend is 4 August 2023.
- The dividend is fully franked.
- WMA maintains a focus on providing consistent income to shareholders.
- The company invests in a diversified portfolio of alternative assets.
- WMA aims for attractive risk-adjusted returns and steady distributions.
- The announcement reflects WMA's commitment to prudent investment management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Washington H. Soul Pattinson and Co. Limited (SOL) ORDINARY FULLY PAID |
Financials |
$15,296 |
SOL Notice of General Meeting & Proxy Form
|
5 Aug 2025 9:30AM |
$40.310 |
$40.260 |
fallen by
0.12%
|
|
| Teaminvest Private Group Limited (TIP) ORDINARY FULLY PAID |
Financials |
$36 |
Update - Notification of buy-back - TIP
|
5 Aug 2025 9:29AM |
$1.750 |
$1.330 |
fallen by
24%
|
|
| TMK Energy Limited (TMK) ORDINARY FULLY PAID |
Energy |
$36 |
Strategic Alliance to Accelerate Field Development Planning
|
5 Aug 2025 9:28AM |
$0.003 |
$0.165 |
risen by
6,500%
|
|
TMK - Price-sensitive ASX Announcement
Full Release
Key Points
- TMK Energy Limited has announced a strategic alliance to accelerate field development planning for its Gurvantes XXXV Coal Seam Gas Project in Mongolia.
- The alliance is formed with Talon Energy Ltd and a global engineering consultancy group.
- The strategic alliance will focus on advancing the project's technical, commercial, and environmental workstreams.
- The alliance aims to fast-track the development of the project by leveraging the expertise and resources of all parties involved.
- TMK has recently completed successful pilot well testing, confirming the commercial potential of the project's gas resources.
- The company is progressing towards a field development plan, with the goal of delivering first gas production as soon as possible.
- This partnership signifies a major step forward in positioning the Gurvantes XXXV Project as a significant source of gas supply for the Mongolian and potentially Chinese markets.
- TMK Energy Limited remains committed to environmental sustainability and responsible resource development.
- The announcement underscores TMK's strategy to unlock the value of its Mongolian gas assets and meet the region's growing energy demand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Trigg Minerals Limited (TMG) ORDINARY FULLY PAID |
Materials |
- |
Trading Halt
|
5 Aug 2025 9:28AM |
$0.110 |
$0.120 |
risen by
9.09%
|
|
TMG - Price-sensitive ASX Announcement
Full Release
Key Points
- Trigg Minerals Limited (ASX: TMG) requested a trading halt on 13 June 2024.
- The trading halt is related to a proposed capital raising.
- The halt ensures an orderly market in TMG's securities while material information is finalized and released.
- Normal trading will resume at the earliest of 17 June 2024 or upon an announcement regarding the capital raising.
- The request was made to the ASX in accordance with listing rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| APC Minerals Limited (APC) ORDINARY FULLY PAID |
Materials |
$7 |
Notification of cessation of securities - APC
|
5 Aug 2025 9:26AM |
$0.008 |
$0.010 |
risen by
25%
|
|
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$71 |
FDA feedback received for head & neck cancer in CPS below 1
|
5 Aug 2025 9:26AM |
$0.260 |
$0.048 |
fallen by
81.54%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Immutep received positive feedback from the US FDA for a registrational clinical trial design.
- The trial is for first-line HNSCC patients with CPS below 1, an underserved subgroup.
- FDA agreed with a randomized, controlled trial of efti in combination with pembrolizumab.
- Patients with CPS <1 have limited benefit from current immunotherapies.
- Immutep will submit a Special Protocol Assessment (SPA) and IND application.
- Continued engagement with regulatory agencies in the US and Europe is planned.
- Efti is Immutep's lead immunotherapy candidate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$41 |
Application for quotation of securities - PCK
|
5 Aug 2025 9:25AM |
$0.035 |
$0.195 |
risen by
457.14%
|
|
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$393 |
Update - Notification of buy-back - PE1
|
5 Aug 2025 9:24AM |
$1.275 |
$1.470 |
risen by
15.29%
|
|
| Lincoln Minerals Limited (LML) ORDINARY FULLY PAID |
Materials |
$31 |
Renounceable Entitlement Issue Prospectus
|
5 Aug 2025 9:24AM |
$0.008 |
$0.012 |
risen by
50%
|
|
LML - Price-sensitive ASX Announcement
Full Release
Key Points
- Lincoln Minerals Limited is conducting a pro-rata renounceable entitlement offer to raise capital.
- The offer is for one new share for every one existing share held, at $0.005 per new share, with one attaching option for every two new shares.
- The funds raised will be used for exploration activities, tenement expenses, administration, and offer costs.
- The prospectus sets out eligibility, application process, and key dates for shareholders.
- Risks outlined include exploration, funding, market, and regulatory risks.
- Board and management disclosures, interests, and company governance are detailed.
- Information is provided on the impact of the offer on share capital and major shareholders.
- Legal, tax, and ASX compliance requirements are addressed.
- Details about the rights and liabilities of new shares and options are included.
- Potential effects on company control and handling of shortfall shares are explained.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$227 |
PCX Webinar Presentation
|
5 Aug 2025 9:24AM |
$2.060 |
$1.980 |
fallen by
3.88%
|
|
| European Lithium Limited (EUR) ORDINARY FULLY PAID |
Materials |
$374 |
Exceptional Diamond Drill Results Tanbreez
|
5 Aug 2025 9:23AM |
$0.078 |
$0.215 |
risen by
175.64%
|
|
| Askari Metals Limited (AS2) ORDINARY FULLY PAID |
Materials |
$7 |
Askari Completes Technical Due Diligence at Nejo Project
|
5 Aug 2025 9:23AM |
$0.011 |
$0.009 |
fallen by
18.18%
|
|
AS2 - Price-sensitive ASX Announcement
Full Release
Key Points
- Askari Metals Limited completed technical due diligence at the Nejo Project in Ethiopia.
- Due diligence included site visits, review of previous exploration work, and geological assessment.
- Nejo Project shows potential for lithium and gold mineralization, with known pegmatite and artisanal gold activity.
- The AS2 technical team confirmed high-priority targets and opportunities for future exploration.
- Next steps involve negotiating commercial terms and formalizing agreements to proceed with the project.
- The project is considered logistically accessible and has local government support.
- Further exploration activities are planned, including detailed sampling and drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lindian Resources Limited (LIN) ORDINARY FULLY PAID |
Materials |
$1,448 |
Trading Halt
|
5 Aug 2025 9:22AM |
$0.094 |
$0.865 |
risen by
820.21%
|
|
LIN - Price-sensitive ASX Announcement
Full Release
Key Points
- Lindian Resources Limited (ASX:LIN) requested a trading halt on its securities.
- The trading halt was requested pending an announcement about a capital raising.
- The halt is to remain until the earlier of the announcement release or the start of trading on 17 June 2024.
- The request was formally made to the ASX's Listings Compliance team.
- The announcement was signed by Managing Director, Alistair Stephens.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$34 |
Proposed Share Placement
|
5 Aug 2025 9:22AM |
$0.006 |
$0.011 |
risen by
83.33%
|
|
AAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Antilles Gold Limited proposes a share placement to raise capital.
- The placement is aimed at institutional and sophisticated investors.
- Funds will support ongoing exploration and development in Cuba.
- Key projects include the La Demajagua open pit and Nueva Sabana ventures.
- Placement price is at a discount to recent market prices.
- Strengthened financial position will support joint ventures with Cuban partners.
- Negotiations with Cuban authorities have progressed significantly.
- The capital raise is viewed as strategic for future growth and operational progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catapult Sports Ltd (CAT) ORDINARY FULLY PAID |
Information Technology |
$1,047 |
Catapult 2025 AGM - Presentation
|
5 Aug 2025 9:21AM |
$6.550 |
$3.410 |
fallen by
47.94%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$11 |
Notification regarding unquoted securities - ADR
|
5 Aug 2025 9:21AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
| EBR Systems Inc (EBR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$288 |
Final CMS Approval Received for NTAP Reimbursement
|
5 Aug 2025 9:21AM |
$1.340 |
$0.640 |
fallen by
52.24%
|
|
EBR - Price-sensitive ASX Announcement
Full Release
Key Points
- CMS has granted Final Approval for NTAP reimbursement for EBR Systems’ WiSE CRT System.
- NTAP reimbursement will provide enhanced Medicare payments for hospitals using the WiSE CRT System.
- Approval is effective for the 2025 US government fiscal year starting October 1, 2024.
- The WiSE CRT System is the only FDA-approved wireless endocardial pacing system for heart failure patients with CRT indication.
- NTAP designation recognizes the WiSE CRT System as a new, innovative technology with substantial clinical benefit.
- The approval supports broader US adoption and accessibility of the WiSE CRT System for eligible patients.
- EBR Systems Inc expects the NTAP designation to significantly benefit hospitals and patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catapult Sports Ltd (CAT) ORDINARY FULLY PAID |
Information Technology |
$1,047 |
Catapult Reaffirms Guidance, CEO & MD Address
|
5 Aug 2025 9:21AM |
$6.550 |
$3.410 |
fallen by
47.94%
|
|
Call 1300 880 160
Start a chat
Schedule a call
